Effect of off-label targeted drugs on long-term survival in chronic thromboembolic pulmonary hypertension: Insights from a national multicentre prospective registry
This site uses cookies. By continuing to use this site, you consent to the use of cookies.
For more information about cookies, click here. Cookie PolicyOK